Keywords: dyax, deal, astrazeneca, antibody, discovery, corp, usa

Dyax deal with AstraZeneca on antibody discovery

Article | 20 May 2002

Print This

Dyax Corp of the USA has announced a collaboration and license agreementwith drug major AstraZeneca that involves Dyax's proprietary antibody ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in